Coral Gables, FL — Catalyst Pharmaceutical Partners, Inc. announced that on Tuesday, June 15th at 5:20pm local time, Charles Gorodetzky, MD, PhD will deliver a presentation entitled "Vigabatrin for the treatment of stimulant dependence" at the College on Problems of Drug Dependence's (CPDD) 72nd Annual Meeting in Scottsdale, Arizona.
Dr. Gorodetzky, Catalyst's Chief Medical Officer, will present an overview of nonclinical and clinical data obtained from studies of vigabatrin conducted to date which support its continued development as a treatment for cocaine and methamphetamine addiction. Further, the company reported that the presentation materials from the conference will be posted on June 15th on the company's website, www.catalystpharma.com, under "Events and Presentations."
|
RSS - Blogs
